CN
ClearPoint Neuro, Inc.
SEC filingBiotechnology · Solana Beach, CA
Amount raised$17.9Msold at filing
Total offering$17.9M
Investors in the raise46count reported to the SEC
FiledFeb 5, 2026first sale Nov 20, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Danilo T. D'AlessandroExecutive Officer
Matthew B. KleinDirector
Timothy T. RichardsDirector
Mazin L. SabraExecutive Officer
Jeremy L. StigallExecutive Officer
R. John FletcherDirector
Linda M. LiauDirector
Pascal E.R. GirinDirector
Lynnette C. FallonDirector
Joseph M. BurnettExecutive Officer, Director
B. Kristine JohnsonDirector
Executive officers, directors and promoters as listed on the Form D.